Luca Bollo

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Luca Bollo

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Projects

Mecanismos subyacentes del daño axonal y discapacidad en enfermedad asociada a anticuerpos anti-MOG: Estudio MOGAXON

IP: Alvaro Cobo Calvo
Collaborators: Cristina Auger Acosta, Miguel Angel Robles Sanchez, Elisa Marín Ordovás, Mireia Castillo Juarez, Luca Bollo
Funding agency: Instituto de Salud Carlos III
Funding: 201875
Reference: PI24/00859
Duration: 01/01/2025 - 31/12/2027

Related news

Vall d’Hebron takes a further step towards individualized prediction of multiple sclerosis

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

Equip de Vall d'Hebron que ha participat en els estudis

Vall d’Hebron confirms the safety of live attenuated vaccines in multiple sclerosis

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.